Clp-targeting BacPROTACs impair mycobacterial proteostasis and survival.
BacPROTAC
Clp protease
ClpC1
Mycobacterium tuberculosis
antibiotics
cyclomarin A
ecumicin
protein quality control
small-molecule degrader
targeted protein degradation
Journal
Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066
Informations de publication
Date de publication:
11 05 2023
11 05 2023
Historique:
received:
11
10
2022
revised:
24
02
2023
accepted:
05
04
2023
medline:
15
5
2023
pubmed:
4
5
2023
entrez:
3
5
2023
Statut:
ppublish
Résumé
The ClpC1:ClpP1P2 protease is a core component of the proteostasis system in mycobacteria. To improve the efficacy of antitubercular agents targeting the Clp protease, we characterized the mechanism of the antibiotics cyclomarin A and ecumicin. Quantitative proteomics revealed that the antibiotics cause massive proteome imbalances, including upregulation of two unannotated yet conserved stress response factors, ClpC2 and ClpC3. These proteins likely protect the Clp protease from excessive amounts of misfolded proteins or from cyclomarin A, which we show to mimic damaged proteins. To overcome the Clp security system, we developed a BacPROTAC that induces degradation of ClpC1 together with its ClpC2 caretaker. The dual Clp degrader, built from linked cyclomarin A heads, was highly efficient in killing pathogenic Mycobacterium tuberculosis, with >100-fold increased potency over the parent antibiotic. Together, our data reveal Clp scavenger proteins as important proteostasis safeguards and highlight the potential of BacPROTACs as future antibiotics.
Identifiants
pubmed: 37137307
pii: S0092-8674(23)00404-X
doi: 10.1016/j.cell.2023.04.009
pii:
doi:
Substances chimiques
Antitubercular Agents
0
Bacterial Proteins
0
Endopeptidase Clp
EC 3.4.21.92
Heat-Shock Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2176-2192.e22Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests K.F., V.M.S., K.R., H.W., and G.B. were employees of Boehringer Ingelheim at the time of this work.